NORD Summit 2026 Banner Ad

acute myeloblastic leukemia without maturation

Download report (PDF)

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.


Disease Overview

An acute myeloid leukemia (AML) characterized by blasts without evidence of maturation to more mature neutrophils. (WHO, 2001)


Synonyms

  • AML M1
  • AML without maturation
  • AWM
  • FAB M1
  • M1 acute granulocytic leukaemia
  • M1 acute granulocytic leukaemia without maturation
  • M1 acute granulocytic leukemia
  • M1 acute granulocytic leukemia without maturation
  • M1 acute myeloblastic leukaemia
  • M1 acute myeloblastic leukaemia without maturation
  • M1 acute myeloblastic leukemia
  • M1 acute myeloblastic leukemia without maturation
  • M1 acute myelocytic leukaemia
  • M1 acute myelocytic leukaemia without maturation
  • M1 acute myelocytic leukemia
  • M1 acute myelocytic leukemia without maturation
  • M1 acute myelogenous leukaemia
  • M1 acute myelogenous leukaemia without maturation
  • M1 acute myelogenous leukemia
  • M1 acute myelogenous leukemia without maturation
  • M1 acute myeloid leukaemia
  • M1 acute myeloid leukaemia without maturation
  • M1 acute myeloid leukemia
  • M1 acute myeloid leukemia without maturation
  • acute M1 myeloid leukaemia
  • acute M1 myeloid leukemia
  • acute granulocytic leukaemia without maturation
  • acute granulocytic leukemia without maturation
  • acute myeloblastic leukaemia M1
  • acute myeloblastic leukaemia type 1
  • acute myeloblastic leukemia M1
  • acute myeloblastic leukemia type 1
  • acute myelocytic leukaemia without maturation
  • acute myelocytic leukemia without maturation
  • acute myelogenous leukaemia without maturation
  • acute myelogenous leukemia without maturation
  • acute myeloid leukaemia without maturation
  • acute myeloid leukaemia without maturation (FAB M1)
  • acute myeloid leukemia without maturation
  • acute myeloid leukemia without maturation (FAB M1)

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report

Access State Report Card Data

Please complete this form to access the requested resource.

Please consider sharing some basic information with us.

Name(Required)
This field is hidden when viewing the form